Prognostic value of clinical and radiomic parameters in patients with liver metastases from uveal melanoma
Pigment Cell & Melanoma Research · 2024
DOI: 10.1111/pcmr.13184 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pigment Cell & Melanoma Research, 2024. Verfasst von Mael Lever und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Essen, Germany. Hauptthemen laut MEDLINE: Uveal Neoplasms, Melanoma, Liver Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Approximately every second patient with uveal melanoma develops distant metastases, with the liver as the predominant target organ. While the median survival after diagnosis of distant metastases is limited to a year, yet‐to‐be‐defined subgroups of patients experience a more favorable outcome. Therefore, prognostic biomarkers could help identify distinct risk groups to guide patient counseling, therapeutic decision‐making, and stratification of study populations. To this end, we retrospectively analyzed a cohort of 101 patients with newly diagnosed hepatic metastases from uveal melanoma by using Cox‐Lasso regression machine learning, adapted to a high‐dimensional input parameter space. We show that substantial binary risk stratification can be performed, based on (i) clinical and laboratory parameters, (ii) measures of quantitative overall hepatic tumor burden, and (iii) radiomic parameters. Yet, combining two or all three domains failed to improve prognostic separation of patients. Additionally, we identified highly relevant clinical parameters (including lactate dehydrogenase, thrombocyte counts, aspartate transaminase, and the metastasis‐free interval) at first diagnosis of metastatic disease as predictors for time‐to‐treatment failure and overall survival. Taken together, the risk stratification models, built by our machine‐learning algorithm, identified a comparable and independent prognostic value of clinical, radiological, and radiomic parameters in uveal melanoma patients with hepatic metastases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Ophthalmology, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Essen, Germany.
- Department of Medical Oncology, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Essen, Germany.
- Institute of Pathology, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Essen, Germany.
- National Center for Tumor Diseases (NCT) West, Essen, Germany.
ORCID-Profile: Halime Kalkavan
Zitieren
APA
Lever, M., Bogner, S., Giousmas, M., Mairinger, F. D., Baba, H. A., Richly, H., Gromke, T., Schuler, M., Bechrakis, N. E., & Kalkavan, H. (2024). Prognostic value of clinical and radiomic parameters in patients with liver metastases from uveal melanoma. Pigment Cell & Melanoma Research. https://doi.org/10.1111/pcmr.13184
Vancouver
Lever M, Bogner S, Giousmas M, Mairinger FD, Baba HA, Richly H, et al. Prognostic value of clinical and radiomic parameters in patients with liver metastases from uveal melanoma. Pigment Cell & Melanoma Research. 2024. doi:10.1111/pcmr.13184
BibTeX
@article{Lever2024,
author = {Lever, Mael and Bogner, Simon and Giousmas, Melina and Mairinger, Fabian D and Baba, Hideo A and Richly, Heike and Gromke, Tanja and Schuler, Martin and Bechrakis, Nikolaos E and Kalkavan, Halime},
title = {Prognostic value of clinical and radiomic parameters in patients with liver metastases from uveal melanoma},
journal = {Pigment Cell & Melanoma Research},
year = {2024},
doi = {10.1111/pcmr.13184}
}
EUVIMED